Advancing manufacture of human mesenchymal stem cells therapies: technological challenges in cell bioprocessing and characterization

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

The use of human mesenchymal stem/stromal cells (hMSC) in clinical trials has been exponentially increasing over the last decade. To meet the high-growth demand for high quality hMSC products, much research and many reports have been published on bioprocess development for hMSC production in bioreactors, their downstream processing and on the development of analytical tools for standardization and harmonization of functional assays to assess hMSC potency. Here we discuss the last advances in hMSC manufacturing that have been designed through a better understanding of the attributes critical for assuring product quality, safety and therapeutic efficacy.

Original languageEnglish
Pages (from-to)226-235
Number of pages10
JournalCurrent Opinion in Chemical Engineering
DOIs
Publication statusPublished - 1 Dec 2018

Fingerprint Dive into the research topics of 'Advancing manufacture of human mesenchymal stem cells therapies: technological challenges in cell bioprocessing and characterization'. Together they form a unique fingerprint.

  • Cite this